Could this AI-Found Peptide Be the Future of Weight Loss?
The researchers used AI-powered analysis and automated systems to uncover BRINP2-related peptide (BRP), a 12-mer peptide that effectively reduces appetite and weight gain in mice and pigs without causing nausea. Unlike existing treatments that target pathways like glucagon-like peptide 1 (GLP-1), BRP operates through an independent mechanism, offering a novel approach to weight management.
Background: Peptide hormones play a vital role in regulating energy balance and have long been explored as potential treatments for obesity. Since the discovery of neuropeptide Y, 12 additional peptides involved in feeding regulation have been identified. However, uncovering new bioactive peptides remains challenging due to their low abundance and difficulty in distinguishing them from degradation byproducts. Traditionally, these peptides were identified from endocrine organs, but systematic efforts to discover novel peptides with therapeutic potential have been limited.
PCSK1 is a key enzyme in peptide processing, with genetic variants linked to obesity in both humans and animals. While peptides like GLP-1 have demonstrated therapeutic potential, the full spectrum of PCSK1-generated peptides remains largely unexplored.
Excerpted from AZO Robotics
